We here show that inhibition of Bcl-xL Ser14 phosphorylation suppresses the hypertrophic signaling mechanism during phenylephrine treatment in vitro, consistent with the notion that Bcl-xL Ser14 phosphorylation mediates adaptive cardiac hypertrophy. Here, BCL2L1 is linked to cardiac hypertrophy.